Amino Acid Residues Critical for Endoplasmic Reticulum Export and Trafficking of Platelet-activating Factor Receptor

被引:22
作者
Hirota, Nobuaki [2 ]
Yasuda, Daisuke
Hashidate, Tomomi
Yamamoto, Teruyasu [3 ]
Yamaguchi, Satoshi [3 ,4 ]
Nagamune, Teruyuki [3 ,4 ]
Nagase, Takahide [2 ]
Shimizu, Takao [1 ,4 ]
Nakamura, Motonao [1 ,4 ]
机构
[1] Univ Tokyo, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Univ Tokyo, Dept Resp Med, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan
[3] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1130033, Japan
[4] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1130033, Japan
基金
日本学术振兴会;
关键词
PROTEIN-COUPLED RECEPTOR; V2; VASOPRESSIN; PHARMACOLOGICAL CHAPERONES; LIGAND-BINDING; TRANSMEMBRANE DOMAINS; IDENTIFICATION; MUTATIONS; RESCUE; INHIBITION; EXPRESSION;
D O I
10.1074/jbc.M109.066282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several residues are conserved in the transmembrane domains (TMs) of G-protein coupled receptors. Here we demonstrate that a conserved proline, Pro(247), in TM6 of platelet-activating factor receptor (PAFR) is required for endoplasmic reticulum (ER) export and trafficking after agonist-induced internalization. Alanine-substituted mutants of the conserved residues of PAFRs, including P247A, were retained in the ER. Because a PAFR antagonist, Y-24180, acted as a pharmacological chaperone to rescue ER retention, this retention is due to misfolding of PAFR. Methylcarbamyl (mc)-PAF, a PAFR agonist, did not increase the cell surface expression of P247A, even though another ER-retained mutant, D63A, was effectively trafficked. Signaling and accumulation of the receptors in the early endosomes were observed in the mc-PAF-treated P247A-expressing cells, suggesting that P247A was trafficked to the cell surface by mc-PAF, and thereafter disappeared from the surface due to aberrant trafficking, e.g. enhanced internalization, deficiency in recycling, and/or accelerated degradation. The aberrant trafficking was confirmed with a sortase-A-mediated method for labeling cell surface proteins. These results demonstrate that the conserved proline in TM6 is crucial for intracellular trafficking of PAFR.
引用
收藏
页码:5931 / 5940
页数:10
相关论文
共 47 条
[1]   Novel mutations in G protein-coupled receptor gene (P2RY5) in families with autosomal recessive hypotrichosis (LAH3) [J].
Azeem, Zahid ;
Jelani, Musharraf ;
Naz, Gul ;
Tariq, Muhammad ;
Wasif, Naveed ;
Naqvi, Syed Kamran-ul-Hassan ;
Ayub, Muhammad ;
Yasinzai, Masoom ;
Amin-ud-Din, Muhammad ;
Wali, Abdul ;
Ali, Ghazanfar ;
Chishti, Muhammad Salman ;
Ahmad, Wasim .
HUMAN GENETICS, 2008, 123 (05) :515-519
[2]   Pharmacological chaperones:: potential treatment for conformational diseases [J].
Bernier, V ;
Lagacé, M ;
Bichet, DG ;
Bouvier, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (05) :222-228
[3]   Molecular tinkering of G protein-coupled receptors: an evolutionary success [J].
Bockaert, J ;
Pin, JP .
EMBO JOURNAL, 1999, 18 (07) :1723-1729
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
CHANDA PK, 1993, MOL PHARMACOL, V43, P516
[6]   G protein-coupled receptor trafficking in health and disease: Lessons learned to prepare for therapeutic mutant rescue in vivo [J].
Conn, P. Michael ;
Ulloa-Aguirre, Alfredo ;
Ito, Joel ;
Janovick, Jo Ann .
PHARMACOLOGICAL REVIEWS, 2007, 59 (03) :225-250
[7]   A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: Implications for family B G-protein-coupled receptors [J].
Conner, AC ;
Hay, DL ;
Simms, J ;
Howitt, SG ;
Schindler, M ;
Smith, DM ;
Wheatley, M ;
Poyner, DR .
MOLECULAR PHARMACOLOGY, 2005, 67 (01) :20-31
[8]  
Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u
[9]   Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor [J].
Fan, JQ ;
Ishii, S ;
Asano, N ;
Suzuki, Y .
NATURE MEDICINE, 1999, 5 (01) :112-115
[10]   Brief report: Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. [J].
Frustaci, A ;
Chimenti, C ;
Ricci, R ;
Natale, L ;
Russo, MA ;
Pieroni, M ;
Eng, CM ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :25-32